PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,892 | +92.3% | 471,012 | +96.0% | 0.00% | +100.0% |
| Q2 2023 | $1,504 | +23.4% | 240,320 | -6.1% | 0.00% | 0.0% |
| Q1 2023 | $1,219 | -13.7% | 255,922 | +57.7% | 0.00% | 0.0% |
| Q4 2022 | $1,412 | -99.9% | 162,319 | -16.3% | 0.00% | -66.7% |
| Q3 2022 | $2,308,000 | +32.0% | 193,871 | +57.9% | 0.00% | +200.0% |
| Q2 2022 | $1,748,000 | +860.4% | 122,751 | +1309.5% | 0.00% | – |
| Q1 2022 | $182,000 | – | 8,709 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 3,869,911 | $115,323,000 | 47.76% |
| Euclidean Capital LLC | 2,769,813 | $82,540,000 | 40.12% |
| Logos Global Management LP | 1,400,000 | $41,720,000 | 3.01% |
| Orbimed Advisors | 7,330,423 | $218,447,000 | 2.40% |
| Boxer Capital, LLC | 2,268,236 | $67,593,000 | 2.36% |
| PERSONAL CFO SOLUTIONS, LLC | 355,342 | $10,589,000 | 2.17% |
| Asymmetry Capital Management, L.P. | 100,882 | $3,006,000 | 1.81% |
| Avoro Capital Advisors LLC | 2,925,000 | $87,165,000 | 1.37% |
| COMMODORE CAPITAL LP | 125,000 | $3,725,000 | 0.98% |
| HighVista Strategies LLC | 39,777 | $1,185,000 | 0.78% |